Thonningianin A disrupts pA104R-DNA binding and inhibits African swine fever virus replication.
Li, Q.J., Shao, H.H., Zheng, L.L., Liu, Q., Huo, C.C., Yi, D.R., Feng, T., Cen, S.(2025) Emerg Microbes Infect 14: 2482697-2482697
- PubMed: 40138179 
- DOI: https://doi.org/10.1080/22221751.2025.2482697
- Primary Citation of Related Structures:  
9JS5 - PubMed Abstract: 
African swine fever is a highly lethal disease caused by the African swine fever virus (ASFV), posing a significant threat to the global pig industry, wherease no approved treatments are currently available. The ASFV DNA-binding protein, pA104R, plays a critical role in viral genome packaging and replication, making it a key target for drug discovery. Through structure-based virtual screening, we identified a polyphenolic compound, thonningianin A, which disrupts the pA104R-DNA binding and significantly inhibits ASFV replication. Mechanistic study revealed that thonningianin A binds to the DNA-binding region of pA104R, forming strong hydrogen bonds with H100 and occupying the vital DNA-binding residues K92, R94, and K97. In addition, we resolved the high-resolution (1.8 Å) structure of pA104R (PDB ID 9JS5), providing valuable insights for future drug screening. Together, these results demonstrate that thonningianin A holds great potential for the development of anti-ASFV drug, as a herb extract with favourable pharmacokinetic properties and safety.
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
Organizational Affiliation: